Health

Emerging Field of Companion Diagnostics or ‘Theranostics’ Helps Drive In Vitro Diagnostics (IVD) Market



01.08.2008 18:46:03 Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report which finds that ‘theranostics’, a fusion of drug therapy and diagnostics is garnering strong interest in the IVD market.

(live-PR.com) - Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report which finds that ‘theranostics’, a fusion of drug therapy and diagnostics is garnering strong interest in the IVD market.

The report, “In Vitro Diagnostics Market Report & Analysis 2008-2023” which is available at www.piribo.com/search/results.html?k=VIS073&x=0& .. finds that this type of combination which
is also called companion diagnostics, integrated medicine, pharmacodiagnostics and Dx/Rx partnering is done to optimise efficacy and safety and streamline drug development.

The report finds that this emerging field is generating strong interest from the
healthcare industry and regulatory bodies, with the associated market expanding as the importance of theranostics is recognised, especially in the treatment of cancer.

Authors of the report say that the markets for In Vitro Diagnostics will exhibit strong growth in revenue from 2008-2023 as technological solutions are playing an increasingly important role in both clinical practice and pharmaceutical R&D. These technological solutions help to increase safety, speed up clinical development and facilitate regulatory acceptance.

Additionally the study finds that current developments in diagnostics - especially molecular diagnostics - are paving the way towards the long-held goal of personalised medicine.

The study examines the market for in vitro diagnostic solutions critically, through
comprehensive primary and secondary research. It concentrates on the following essential aspects of the in vitro diagnostics sector:

• Technologies that drive the IVD sector, including those related to
theranostics

• Key industrial players in IVD - both established and emerging - including
partnerships

• Forecasts of the global IVD market from 2008-2023 - including those of
principal market segments, both by disease area and technology

• Forecasts for IVD sales in leading national markets, including China and
India

• Forecasts for theranostic applications - including therapeutic areas -
from 2008-2023

“In Vitro Diagnostics Market Report & Analysis 2008-2023” is available in pdf format from Piribo.

For more information, go to:
www.piribo.com/publications/diagnostic/invitro_d ..

Piribo product ID: VIS073

About Piribo.
Piribo (http:www.piribo.com) is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 10,000 English language titles including, market reports, studies and books and is the UK’s largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.


Contact information:
Piribo Ltd

54 Maltings Place
169 Tower Bridge Road
London
SE1 3LJ
UK

Contact Person:
Urmila Doraswami
Press Release Writer
Phone: +44 (0) 20 7060 7474
eMail: eMail

Web: http://www.piribo.com

Author:
Urmila Doraswami
e-mail
Web: http://www.piribo.com
Phone: press@reportbuyer.com


 

Disclaimer: If you have any questions regarding information in this article please contact the author. Please do not contact Live-PR.com. We are not able to assist you. Live-PR.com disclaims content contained in this article. Live-PR.com is not authorized to give any information about content and not responsible for content posted by third party.
refer this article
Print This Article
Terms Of Use About Live-PR.com Contact Us